Understanding the inflammatory basis of MDD can aid in the identification of specific biomarkers of inflammation such as IL-6 and CRP to provide a more personalized treatment approach and informed therapeutic strategy in patients with Treatment Resistant Depression (TRD) (Jha and Trivedi, 2018). This evidence concerns the gene IL6 and treatment resistant depression.